MELVILLE, N.Y.--(BUSINESS WIRE)--OSI Pharmaceuticals, Inc. (NASDAQ: OSIP) announced today that Colin Goddard Ph.D., Chief Executive Officer of OSI Pharmaceuticals, will present at the Merrill Lynch Conference in New York, NY on Thursday, February 8, 2007 at 2:20pm (Eastern Time). Dr. Goddard will provide an overview on the Company’s product portfolio and business developments.
